The brain is the one organ that absolutely cannot be transplanted from one person to another, and it likely never will be in any meaningful sense. Beyond the brain, several other organs and tissues remain off the table for routine donation, including the spinal cord, the eyes as whole functioning units, and most endocrine glands like the thyroid and pituitary. The reasons vary from organ to organ, though, and the line between “cannot be donated” and “not yet routinely donated” shifts as medicine advances.
Why the Brain Cannot Be Transplanted
The brain stands alone as the organ that is fundamentally untransferable. Every other organ in the body serves a function that, at least in theory, another person’s organ could replicate. The brain is different because it does not just perform a biological task; it is the seat of a person’s identity, memory, and consciousness. Even if you could physically place one person’s brain into another person’s skull, the recipient would not be the same person anymore. The philosophical problem is as large as the surgical one.
The surgical problem itself is immense. The brain connects to the rest of the body through the spinal cord, which contains roughly a million nerve fibers bundled into a cable about the diameter of your thumb. Severing those connections is easy. Reconnecting them so that electrical signals flow correctly from brain to body has never been achieved in humans. Some researchers have argued that advances in spinal cord fusion and immunology make whole-brain transplantation “technically feasible,” but that claim remains deeply controversial and has not been demonstrated in any clinical setting.1PubMed Central. Whole brain transplantation in man: Technically feasible The brain also tolerates oxygen deprivation extremely poorly. Neurons begin dying within minutes of losing blood supply, which makes the logistics of removing, transporting, and reconnecting a brain essentially impossible with current preservation technology.
Whole Eyes and the Optic Nerve Problem
Corneal transplants are among the most common and successful tissue transplants in the world. But a cornea is just one thin layer at the front of the eye. Transplanting an entire eye, so that a blind person could see through a donor’s eye, remains beyond reach. The core obstacle is the optic nerve, which carries visual information from the retina to the brain. Like the spinal cord, the optic nerve is part of the central nervous system, and central nervous system tissue does not regenerate the way peripheral nerves sometimes can.
Researchers are exploring ways to encourage optic nerve regrowth using growth factors and immune-modulating treatments, but the inhibitory environment of the central nervous system has so far prevented successful regeneration.2PubMed Central. Whole-eye transplantation: Current challenges and future perspectives Even if a transplanted eye survived immunologically, the roughly 1.2 million nerve fibers in the optic nerve would need to find their correct targets in the brain for the person to perceive coherent images. That problem has no solution on the horizon. In 2024, surgeons at NYU performed the first whole-eye transplant as part of a partial face transplant, but the transplanted eye has not restored vision. It survived and maintained blood flow, which was considered a milestone, but the nerve connection issue remains unresolved.
Endocrine Glands That Nobody Transplants
Your body has several small but vital glands that produce hormones: the thyroid, the parathyroids, the pituitary, and the adrenal glands, among others. None of these are part of routine organ donation, and the reason is surprisingly practical. Hormone replacement therapy works well enough that transplanting a gland would be medically unjustifiable for most patients. If your thyroid is removed, you take a daily pill of synthetic thyroid hormone and live a normal life. A transplant would require major surgery, lifelong immunosuppressive drugs, and the risk of rejection, all to replace something a cheap pill already handles.
Endocrine glands also present unique immunological challenges. They are small, highly vascularized, and their cells can provoke immune responses that are disproportionate to the organ’s size.3PubMed Central. Is thyroid transplantation on the distant horizon? The one major exception in the endocrine family is the pancreas, which is routinely transplanted because the insulin-producing function it provides is far harder to replicate artificially than thyroid hormone or cortisol. Insulin pumps and injections work, but they do not match the minute-by-minute glucose regulation of a functioning pancreas, which is why pancreas transplants exist for severe diabetes cases.
The Spleen and Lymphoid Tissue
The spleen filters blood, recycles old red blood cells, and plays a significant role in immune function. Despite its importance, it is not transplanted as a standalone organ. People who lose their spleen to injury or surgery can live without one, though they become more vulnerable to certain bacterial infections. The deeper issue with spleen transplantation is immunological: the spleen is packed with immune cells, and transplanting it from one person to another introduces a massive army of foreign immune cells into the recipient’s body.
When surgeons first attempted to include a donor spleen as part of combined organ transplants (paired with the pancreas), the results were alarming. Several recipients developed graft-versus-host disease, a condition in which the donor’s immune cells attack the recipient’s body rather than the other way around. Early cases were sometimes fatal, and the practice of intentionally including the spleen was largely abandoned.4PubMed Central. Transplantation of the Spleen: Effect of Splenic Allograft in Human Multivisceral Transplantation The spleen’s inclusion in multivisceral transplants (where several abdominal organs are transplanted together) has been revisited more recently under more carefully managed immunosuppression protocols, but the spleen remains an organ that nobody transplants on its own.
Other lymphoid tissues present similar problems. Lymph nodes, the thymus, and bone marrow are all heavily populated with immune cells. Bone marrow transplantation does exist, of course, but it operates on entirely different principles: the recipient’s immune system is deliberately destroyed first, and the donor marrow rebuilds it from scratch. That approach works for bone marrow precisely because replacing the immune system is the goal. For solid organs filled with immune tissue, the same immune cell cargo is a threat, not a benefit.
Reproductive Organs and the Shifting Boundary
Reproductive organs sit in an interesting gray zone. For most of transplant history, they were considered non-transplantable. That has changed dramatically in recent years. Uterus transplantation has moved from experimental to clinically successful, with dozens of babies born worldwide to women who received a transplanted uterus. The uterus is now an organ that can be donated, though the procedure remains rare and is performed at only a handful of centers.
Ovarian and testicular tissue transplantation is a different story. Both have been performed, but almost exclusively as autotransplants, meaning a person’s own tissue is removed, stored, and later reimplanted in the same body. The first documented ovarian tissue autotransplant resulting in pregnancy dates to 2004, in a woman whose tissue was frozen before chemotherapy and returned afterward. Testicular tissue was similarly reimplanted in a man after cancer treatment as early as 2001, and he subsequently fathered a child.5Dove Medical Press. Ethical considerations in uterus transplantation Transplanting ovarian or testicular tissue between unrelated people raises unique ethical concerns because these tissues carry the donor’s genetic material. A child conceived using a transplanted ovary would be the genetic offspring of the donor, not the recipient. That is a fundamentally different situation from receiving a donated kidney, which does not change your DNA or your children’s DNA.
Between identical twins or in rare cases of bone marrow chimerism (where one sibling’s immune system has been replaced by another’s), ovarian tissue has been transplanted between two people. But for the general population, gonads remain organs that are not donated to unrelated recipients.
Why Organs That Can Be Donated Sometimes Cannot Be Used
The question of which organs “cannot” be donated also has a practical dimension that many people do not consider. Even for organs that are routinely transplanted, like hearts, lungs, livers, and kidneys, a large proportion of donated organs go unused. The reasons boil down to time, condition, and fit.
Every organ has a clock that starts ticking the moment blood stops flowing through it. For kidneys, the window is relatively generous, long enough that they can be packed on ice and shipped on commercial flights. For hearts, the window is much tighter: roughly four to eight hours from procurement to transplantation, which limits how far a heart can travel.6PubMed Central. Freezing Biological Time: A Modern Perspective on Organ Preservation Lungs are similarly fragile. If no matching recipient is close enough geographically, a perfectly healthy organ can go to waste simply because it cannot survive the trip.
Size matching matters more than most people realize, particularly for lungs. If a donor’s lungs are significantly larger or smaller than the recipient’s chest cavity, the transplant is less likely to succeed. A study of over 500 lung transplant recipients found that when donor and recipient lung sizes were well matched, long-term survival improved significantly compared to mismatched cases.7PubMed. A simplified strategy for donor-recipient size-matching in lung transplant for interstitial lung disease Heart size also matters, though surgeons have more flexibility there.
Then there is the question of how the donor died. In traditional organ donation, the donor is brain-dead but still on a ventilator, meaning the organs are receiving oxygenated blood right up until they are removed. Donation after circulatory death, where the heart has stopped, introduces a period of warm ischemia that damages organs. The heart is particularly vulnerable here because after the ventilator is removed, the heart struggles against worsening oxygen deprivation, undergoes a surge of stress hormones, and rapidly depletes its energy reserves before finally stopping.8Frontiers in Cardiovascular Medicine. Transplantation of Hearts Donated after Circulatory Death Standard cold-storage techniques that work for brain-dead donor hearts are often inadequate for hearts that have already sustained this kind of injury.9PubMed. Organ donation after circulatory death: current status and future potential
Blood Type and Immune Compatibility
Even when an organ is healthy, well-preserved, and the right size, it can still be unusable for a specific recipient because of immune incompatibility. Solid organ transplantation has long been governed by blood group matching. Transplanting an organ across the ABO blood group barrier risks hyperacute rejection, where the recipient’s immune system attacks the new organ within minutes to hours, destroying it before it ever has a chance to function.10PubMed. Current experience with renal transplantation across the ABO barrier Desensitization protocols have been developed that allow some blood-type-incompatible kidney transplants to proceed, but for hearts and other organs, the barrier remains much harder to cross.
Beyond blood type, the immune system uses a set of cell-surface markers to distinguish self from foreign tissue. When a donor and recipient are poorly matched on these markers, rejection rates climb. For kidneys, the system for matching is well established and tolerated mismatches are common with adequate immunosuppression. For more immunologically sensitive tissues, matching requirements are stricter, and the pool of acceptable donors shrinks accordingly.
Face and Hand Transplants Push the Definition
The concept of organ donation expanded in unexpected directions when surgeons began transplanting composite structures: hands, arms, faces, and even penises. These are called vascularized composite allografts because they involve multiple tissue types (skin, muscle, bone, nerves, blood vessels) all connected and transplanted as a single unit. They are technically “donatable,” but they occupy a strange space in transplant medicine because the immunological challenges are far more complex than those seen with internal organs.
Each tissue type within a composite graft has its own immunological properties, which means the immune system has multiple fronts on which to attack the transplant.11PubMed. The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective Face transplants, which include mucosal tissue (the moist lining inside the mouth and nose), appear to be more immunogenic than hand transplants, leading to higher rates of rejection episodes.12PubMed Central. Immunosuppressive strategies in face and hand transplantation: a comprehensive systematic review of current therapy regimens and outcomes Recipients of these transplants require heavy lifelong immunosuppression, and some hand transplant recipients have ultimately had their grafts removed because the side effects of the drugs were worse than returning to a prosthesis. These are organs and tissues that can be donated, but the cost-benefit calculus is far less clear-cut than for a lifesaving heart or kidney.
Pediatric and Neonatal Donation Constraints
Donation from very young children and newborns adds another set of limitations. Infant organs are tiny, which restricts the pool of potential recipients to other small children. Brain death is also harder to diagnose in neonates, and the ethical framework is more contested. Some programs have explored recovery from neonates born with immediately lethal conditions, such as anencephaly, but these efforts remain limited in scope and surrounded by ethical debate.13PubMed Central. Neonatal and Pediatric Organ Donation: Ethical Perspectives and Implications for Policy The result is that pediatric organ donation rates remain low relative to adult rates, and many children on transplant waiting lists wait significantly longer than adults.
Technologies That Are Changing What Counts as “Usable”
The list of non-transplantable organs is getting shorter, not longer, thanks to several technologies that are working to reclaim organs previously considered too damaged or too fragile for transplant.
Ex vivo machine perfusion is the most impactful recent development. Instead of simply packing an organ on ice (the standard for decades), machine perfusion keeps an organ warm or slightly cool, pumps oxygenated fluid through its blood vessels, and allows doctors to monitor the organ’s function in real time outside the body. This technique has extended preservation times, allowed organs from donors who died after circulatory arrest to be resuscitated, and expanded the pool of usable organs considerably.14PubMed Central. Pushing the boundaries of innovation: the potential of ex vivo organ perfusion from an interdisciplinary point of view For livers in particular, machine perfusion at slightly below body temperature has shown the ability to restore metabolic function in organs that had been discarded as unusable, improving oxygen uptake, clearing waste products, and even producing bile.15American Journal of Transplantation. Subnormothermic Machine Perfusion for Ex Vivo Preservation and Recovery of the Human Liver for Transplantation
Researchers are also using the perfusion window to actively treat organs before transplanting them. A systematic review of therapeutic interventions during machine perfusion identified approaches ranging from pharmacologic agents that rescue mitochondrial function to cellular therapies using stem cells to repair structural injuries. Molecular-level improvements were reported in nearly all studies, though only about a third showed clear functional improvement, which highlights the gap between laboratory promise and clinical readiness.16PubMed Central. From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Xenotransplantation, using genetically modified pig organs in human recipients, represents another frontier. Pig organs are roughly the right size for humans, and CRISPR-based gene editing has enabled scientists to remove the pig antigens that trigger immediate immune rejection and add human immune-regulatory proteins.17PubMed Central. Current Techniques of Gene Editing in Pigs for Xenotransplantation Pig kidneys and hearts have been transplanted into a small number of human patients in recent years, with survival measured in weeks to months so far. The technology is not ready for routine use, but it could eventually make certain organ shortages irrelevant by providing an unlimited supply of organs grown to order.
3D bioprinting aims to sidestep the donor problem entirely by building organs from a patient’s own cells. The field has made real progress in printing small tissue structures and developing the bioinks needed to support living cells, but printing a fully functional organ with its own blood vessel network remains a significant engineering challenge.18PubMed Central. Advances and Challenges in 3D Bioprinting for Organ Transplantation: Bridging the Gap Between Research and Clinical Applications The most promising near-term applications are for simpler tissues like cartilage, skin patches, and small blood vessels rather than complex solid organs like kidneys or livers. A fully bioprinted transplantable kidney remains years, possibly decades, away.